Branislav Bystrický
Impact in
-
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
-
- Oral health in cancer treatment
Papers in
- Oncology 9
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Lung Cancer Treatments and Mutations 2
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Michal Mego (8 shared papers)Jozef Chovanec (4 shared papers)Mária Rečková (4 shared papers)Daniela Světlovská (4 shared papers)Jozef Mardiak (4 shared papers)Ľuboš Drgoňa (4 shared papers)Věra Miškovská (2 shared papers)Ian Chau (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Frontiers in Oncology (2 papers)Anticancer Research (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- SlovakiaUnited KingdomUnited States
In The Last Decade
Branislav Bystrický
24 papers receiving 343 citations
Peers
Comparison fields: 5 of 67
- Oncology 120
- Pulmonary and Respiratory Medicine 78
- Internal Medicine 8
- Cancer Research 32
- Molecular Biology 152
Countries citing papers authored by Branislav Bystrický
This map shows the geographic impact of Branislav Bystrický's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branislav Bystrický with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branislav Bystrický more than expected).
Fields of papers citing papers by Branislav Bystrický
This network shows the impact of papers produced by Branislav Bystrický. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branislav Bystrický. The network helps show where Branislav Bystrický may publish in the future.
Co-authors
The 25 scholars most cited alongside Branislav Bystrický, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 184 | |
| 2 | 2010 | 23 | |
| 3 | 2017 | 16 | |
| 4 | 2011 | 15 | |
| 5 | 2010 | 15 | |
| 6 | 2023 | 13 | |
| 7 | 2015 | 11 | |
| 8 | 2017 | 10 | |
| 9 | 2016 | 8 | |
| 10 | 2016 | 7 | |
| 11 | 2024 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2021 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2017 | 5 | |
| 16 | 2016 | 4 | |
| 17 | 2012 | 3 | |
| 18 | 2019 | 2 | |
| 19 | 2015 | 2 | |
| 20 | 2014 | 2 |
About Branislav Bystrický
Branislav Bystrický is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Epidemiology and Cancer Research, having authored 25 papers that have together received 345 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (2 papers), Multiple and Secondary Primary Cancers (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Cancer Genomics and Diagnostics (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (120 citations), Pulmonary and Respiratory Medicine (78 citations), Internal Medicine (8 citations), Cancer Research (32 citations) and Molecular Biology (152 citations). Branislav Bystrický has collaborated with scholars based in Slovakia, United Kingdom and United States. Frequent co-authors include Michal Mego, Jozef Chovanec, Mária Rečková, Daniela Světlovská, Jozef Mardiak, Ľuboš Drgoňa, Věra Miškovská, Ian Chau, Vladimír Zajac and S. Špánik. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Anticancer Research, Critical Reviews in Oncology/Hematology and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.